Genetic Variation of Aggrecanase-2 (ADAMTS5) in Susceptibility to Osteoarthritis

Overview

Journal Braz J Med Biol Res

Specialties Biology
General Medicine

Date 2019 Jan 18

PMID 30652828

Citations 11

Authors

Xindie Zhou

Lifeng Jiang

Yi Zhang

Junjie Zhang

Dong Zhou

Lidong Wu

Yong Huang

Nanwei Xu

Affiliations

Soon will be listed here.

Abstract

Aggrecanase-2 (ADAMTS5) gene is responsible for aggrecan degradation that may contribute to cartilage destruction in a mouse osteoarthritis (OA) model. We aimed to investigate the effects of ADAMTS5 gene polymorphisms on OA risk in a Chinese population. A total of 300 OA patients and 300 controls were recruited and their genotypes for ADAMTS5 gene rs226794 and rs2830585 polymorphisms were determined using a custom-by-design 48-Plex single nucleotide polymorphism Scan™ kit. ADAMTS5-associated genes were identified by co-expression analysis and their functions were investigated by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses. Bioinformatics analysis showed that ADAMTS5 was significantly related to the components, structural constituent, and organization of the extracellular matrix. The rs2830585 polymorphism, but not rs226794 polymorphism, was significantly associated with an increased risk of knee OA. Stratified analysis further confirmed this significant association in patients at age ≥55 years. In conclusion, the ADAMTS5 rs2830585 polymorphism may be involved in the development of knee OA by destroying the extracellular matrix, but this finding should be further confirmed by larger studies.

Citing Articles

Etodolac utility in osteoarthritis: drug delivery challenges, topical nanotherapeutic strategies and potential synergies.

Gaddala P, Choudhary S, Sethi S, Sainaga Jyothi V, Katta C, Bahuguna D Ther Deliv. 2024; 15(12):977-995.

PMID: 39345034 PMC: 11583675. DOI: 10.1080/20415990.2024.2405456.

Association of ADAMTS-5 gene polymorphisms with the susceptibility to knee osteoarthritis in a Chinese Han population.

Gao S, Jia M, Wang J, Sun Q, Liu F, Yu L J Orthop Surg Res. 2024; 19(1):513.

PMID: 39192347 PMC: 11348706. DOI: 10.1186/s13018-024-05023-0.

Healthy and Osteoarthritis-Affected Joints Facing the Cellular Crosstalk.

Semenistaja S, Skuja S, Kadisa A, Groma V Int J Mol Sci. 2023; 24(4).

PMID: 36835530 PMC: 9964755. DOI: 10.3390/ijms24044120.

A Meta-Analysis of Non-Osteoarthritis and Osteoarthritis Chondrocyte Gene Expression to Determine the Efficacy of Autologous Chondrocyte Transplantation as a Viable Treatment Option.

Tran T, Sosa B, OConnell A, Chu T, Cottrell J, Chang S Med Case Rep Short Rev. 2021; 2(1).

PMID: 34970658 PMC: 8715826.

The Decisive Case-Control Study Elaborates the Null Association between rs226794 and Osteoarthritis in Asians: A Case-Control Study and Meta-Analysis.

Kao C, Hsu H, Chen Y, Tu M, Chuang S, Su S Genes (Basel). 2021; 12(12).

PMID: 34946864 PMC: 8701278. DOI: 10.3390/genes12121916.

References

Caterson B, Flannery C, Hughes C, Little C . Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol. 2000; 19(4):333-44. DOI: 10.1016/s0945-053x(00)00078-0. View

Tortorella M, Malfait A, Deccico C, Arner E . The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage. 2001; 9(6):539-52. DOI: 10.1053/joca.2001.0427. View

Nagase H, Kashiwagi M . Aggrecanases and cartilage matrix degradation. Arthritis Res Ther. 2003; 5(2):94-103. PMC: 165039. DOI: 10.1186/ar630. View

Little C, Meeker C, Golub S, Lawlor K, Farmer P, Smith S . Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest. 2007; 117(6):1627-36. PMC: 1866253. DOI: 10.1172/JCI30765. View

Goldring M, Goldring S . Osteoarthritis. J Cell Physiol. 2007; 213(3):626-34. DOI: 10.1002/jcp.21258. View

Rodriguez-Lopez J, Mustafa Z, Pombo-Suarez M, Malizos K, Rego I, Blanco F . Genetic variation including nonsynonymous polymorphisms of a major aggrecanase, ADAMTS-5, in susceptibility to osteoarthritis. Arthritis Rheum. 2008; 58(2):435-41. DOI: 10.1002/art.23201. View

Yatabe T, Mochizuki S, Takizawa M, Chijiiwa M, Okada A, Kimura T . Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis. 2008; 68(6):1051-8. PMC: 2674548. DOI: 10.1136/ard.2007.086884. View

Malfait A, Arner E, Song R, Alston J, Markosyan S, Staten N . Proprotein convertase activation of aggrecanases in cartilage in situ. Arch Biochem Biophys. 2008; 478(1):43-51. DOI: 10.1016/j.abb.2008.07.012. View

Cheung K, Hashimoto K, Yamada N, Roach H . Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol Int. 2008; 29(5):525-34. DOI: 10.1007/s00296-008-0744-z. View

10.

Clarke G, Anderson C, Pettersson F, Cardon L, Morris A, Zondervan K . Basic statistical analysis in genetic case-control studies. Nat Protoc. 2011; 6(2):121-33. PMC: 3154648. DOI: 10.1038/nprot.2010.182. View

11.

Li J, Anemaet W, Diaz M, Buchanan S, Tortorella M, Malfait A . Knockout of ADAMTS5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models. J Orthop Res. 2011; 29(4):516-22. DOI: 10.1002/jor.21215. View

12.

Gu J, Rong J, Guan F, Jiang L, Zhang T, Tao S . Association of ADAMTS5 gene polymorphisms with osteoarthritis in Chinese Han population: a community-based case-control study. Rheumatol Int. 2012; 33(11):2893-7. DOI: 10.1007/s00296-012-2506-1. View

13.

Hochberg M, Yerges-Armstrong L, Yau M, Mitchell B . Genetic epidemiology of osteoarthritis: recent developments and future directions. Curr Opin Rheumatol. 2012; 25(2):192-7. PMC: 3771580. DOI: 10.1097/BOR.0b013e32835cfb8e. View

14.

Litwic A, Edwards M, Dennison E, Cooper C . Epidemiology and burden of osteoarthritis. Br Med Bull. 2013; 105:185-99. PMC: 3690438. DOI: 10.1093/bmb/lds038. View

15.

Leung G, Rainsford K, Kean W . Osteoarthritis of the hand I: aetiology and pathogenesis, risk factors, investigation and diagnosis. J Pharm Pharmacol. 2013; 66(3):339-46. DOI: 10.1111/jphp.12196. View

16.

Beyer C, Zampetaki A, Lin N, Kleyer A, Perricone C, Iagnocco A . Signature of circulating microRNAs in osteoarthritis. Ann Rheum Dis. 2014; 74(3):e18. DOI: 10.1136/annrheumdis-2013-204698. View

17.

Itoh Y . Metalloproteinases: potential therapeutic targets for rheumatoid arthritis. Endocr Metab Immune Disord Drug Targets. 2015; 15(3):216-22. DOI: 10.2174/1871530315666150316122335. View

18.

Moazedi-Fuerst F, Gruber G, Stradner M, Guidolin D, Jones J, Bodo K . Effect of Laminin-A4 inhibition on cluster formation of human osteoarthritic chondrocytes. J Orthop Res. 2015; 34(3):419-26. PMC: 5727909. DOI: 10.1002/jor.23036. View

19.

Canbek U, Imerci A, Kara M, Akgun U, Canbek T, Aydogan N . Polymorphisms in ADAMTS4 and ADAMTS5 are not linked to susceptibility to knee osteoarthritis in the Turkish population. Genet Mol Res. 2016; 15(3). DOI: 10.4238/gmr.15038264. View

20.

Silman A . The 1987 revised American Rheumatism Association criteria for rheumatoid arthritis. Br J Rheumatol. 1988; 27(5):341-3. DOI: 10.1093/rheumatology/27.5.341. View